Pluri (PLUR) Interest Coverage Ratio (2022 - 2025)
Pluri (PLUR) reported Interest Coverage Ratio of 28.16 for Q4 2025, down 19.89% year-over-year from 35.16 in Q4 2024, and down 1.57% quarter-over-quarter from 27.73 in Q3 2025.
Pluri (PLUR) Interest Coverage Ratio (2022 - 2025) Analysis & Trends
Pluri (PLUR) has 4 years of Interest Coverage Ratio data on file, last reported at 28.16 in Q4 2025.
- Interest Coverage Ratio for Q4 2025 came in at 28.16, down 19.89% year-over-year; the trailing twelve-month figure through Dec 2025 was 27.49 (down 9.33% YoY), and the FY2025 annual result was 25.4, up 0.72% from the prior year.
- Interest Coverage Ratio eased to 28.16 in Q4 2025 per PLUR's latest filing, from 27.73 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 23.49 in Q4 2024 and troughed at 35.69 in Q3 2022.
- A 4-year average of 27.8 and a median of 27.7 in 2024 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2023 and 2025: Interest Coverage Ratio gained 29.59% in 2023, then retreated 19.89% in 2025.
- A 4-year view of Interest Coverage Ratio shows it stood at 31.5 in 2022, then gained by 23.39% to 24.13 in 2023, then grew by 2.66% to 23.49 in 2024, then dropped by 19.89% to 28.16 in 2025.
- Business Quant data shows PLUR's Interest Coverage Ratio at 28.16 in Q4 2025, 27.73 in Q3 2025, and 28.42 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -258.33 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 11.79 |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | -28.16 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -28.16 |
| Sep 30, 2025 | -27.73 |
| Jun 30, 2025 | -28.42 |
| Mar 31, 2025 | -25.47 |
| Dec 31, 2024 | -23.49 |
| Sep 30, 2024 | -23.95 |
| Jun 30, 2024 | -27.68 |
| Mar 31, 2024 | -25.39 |
| Dec 31, 2023 | -24.13 |
| Sep 30, 2023 | -25.13 |
| Jun 30, 2023 | -29.75 |
| Mar 31, 2023 | -32.72 |
| Dec 31, 2022 | -31.50 |
| Sep 30, 2022 | -35.69 |